dna damage checkpoint activation contributes to the radio
play

DNA damage checkpoint activation contributes to the radio-resistance of mouse mesenchymal stromal cells Tara Sugrue, & Rhodri Ceredig Regenerative Medicine Institute Centre for Chromosome Biology National University of ireland, Galway

0 downloads 6 Views 2 MB Size Report
  1. DNA damage checkpoint activation contributes to the radio-resistance of mouse mesenchymal stromal cells Tara Sugrue, & Rhodri Ceredig Regenerative Medicine Institute Centre for Chromosome Biology National University of ireland, Galway

  2. The DNA Damage Response contributes to MSC radio-resistance

  3. Radiation Response of the Bone Marrow IR Mesenchymal stromal cell Survive (MSC) Die Haematopoietic stem cell (HSC) Haematopoietic failure Rieger K, Marinets O, Fietz T et al. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cells or bone marrow transplantation. Exp Hematol 2005;33:605-611. Dickhut A, Schwerdtfeger R, Kuklick L et al. Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cells transplantation originate from host tissue. Ann Hematol 2005;84:722-727.

  4. Isolation of mouse MSCs CD44 ‘’ Bulk MSCs ’’ CD73 CD90 Heterogenous population. CD105 Sca-1 “CFU-F” Homogenous Mouse MSC line Clonal expansion population

  5. Role of the DNA Damage Response in mediating the radio- resistance of MSCs Mouse mesenchymal stromal Mouse haematopoietic V cell line cell line MS5 ST4.5 CD4 + CD8 + Thymocyte Radio-resistant Radio-sensitive

  6. The DNA Damage Response IR Chromatin DSB Activation of sensor and transducer proteins Signalling to effector proteins Effector Scaffolding Regulatory kinases proteins proteins Cell Cycle Arrest DNA Repair Transcription Apoptosis

  7. Tracking cell cycle progression BrdU G1 S G2 M S G 1 Cell count BrdU G 2 +M S G 2 + M G 1 2n 4n PI DNA content (PI)

  8. MSCs activate IR-induced DNA Damage checkpoints Time post irradiation (10 Gy) 0 hrs 2 hrs 4 hrs 12 hrs S MS5 G 1 G 2 /M ST4.5 BrdU PI 90 % S phase population 80 MS5 Control 70 MS5 10 Gy 60 50 40 30 20 ST4.5 Control 10 ST4.5 10 Gy 0 0 1 2 4 6 8 12 24 36 48 72 Time (Hrs)

  9. MSCs recover from DNA damage checkpoint activaton Time post irradiation (10 Gy) 0 hrs 12 hrs 24 hrs 72 hrs S MS5 G 1 G 2 /M ST4.5 BrdU PI % BrdU labelled G1 population 80 MS5 Control 70 MS5 10 Gy 60 ST4.5 Control 50 40 ST4.5 10 Gy 30 20 10 0 0 1 2 4 6 8 12 24 36 48 72 Time (Hrs)

  10. MSCs suppress IR-induced Apoptosis Time post irradiation (10 Gy) Untreated 2 hrs 4 hrs 12 hrs 36 hrs MS5 ST4.5 PI Annexin V 100 ST4.5 % Annexin V positive cells 80 60 40 20 MS5 0 0 2 4 8 12 24 36 Time post 10 Gy irradiation (Hrs)

  11. Conclusions Ø MSCs survive long-term post high dose γ -irradiation. Ø MSCs activate a robust DNA Damage Response via rapid γ -H2AX formation. Ø MSCs recover from IR-induced DNA damage by: (i) Activating DNA damage checkpoint mechanisms. (ii) Activating DNA DSB repair. (iii) Preventing induction of apoptosis.

  12. Acknowledgements NUI Galway Regenerative Centre for Medicine Institute Chromosome Biology Prof. Rhodri Ceredig Prof. Noel Lowndes Dr. James Brown Genome Stability Prof. Matthew Griffin Laboratory Immunology Group Dr. Michael Rainey Immunology and Transplant Biology Dr. Alessandro Natoni Group Simona Moravcová Michelle Duffy Senthilkumar Alagesan

Recommend Documents


internalization dimerization and activation of cd38
Internalization, Dimerization, and

Internalization, Dimerization, and Activation of CD38 during mNOX Activation:

logistics
Logistics The Renderman Shading

Logistics The Renderman Shading Language Checkpoint 3 Grading underway

logistics
Logistics Checkpoint 2 Mostly graded.

Texture Mapping Logistics Checkpoint 2 Mostly graded. Note on grading --

paper summaries
Paper Summaries Any takers?

Paper Summaries Any takers? Procedural Shading Announcement Logistics

radio radio
RADIO RADIO Ca Cate tegor gory y

This i his is s your br our brain ain on on RADIO RADIO Ca Cate

compilers
Compilers Activation Records Alex

Compilers Activation Records Alex Aiken Activation Records The information

icd 10 checkpoint update for nj hfma
ICD-10 Checkpoint: Update for NJ-HFMA

ICD-10 Checkpoint: Update for NJ-HFMA Jim Hennessy June 2015 e4 Services

assignments
Assignments Checkpoint 6 Tone

Assignments Checkpoint 6 Tone Reproduction Due Monday Another

more ui output tasks damage management layout
More UI Output Tasks: Damage

More UI Output Tasks: Damage Management & Layout Damage management Need

activation
ACTIVATION MARCH 26, 2020 ACTIVATION

ACTIVATION MARCH 26, 2020 ACTIVATION OF POWER Against COVID-19 ZOOM Room

amrutbio overview
AmrutBio Overview A subsidiary of

One-two Punch to Deadly Pancreatic Cancer: Targeted Therapy with Mab AR9.6 and

novel therapeutic for healing gut tissue novel
Novel Therapeutic for Healing Gut

Novel Therapeutic for Healing Gut Tissue Novel Therapeutic for Healing Gut

approaches to identifying approaches to identifying
Approaches to Identifying Approaches

Approaches to Identifying Approaches to Identifying Possible Mechanisms of

structure function analysis of the inositol trisphosphate
Structure-function analysis of the

Structure-function analysis of the inositol trisphosphate receptor and its

activatable molecular probes for optical imaging
Activatable Molecular Probes for

Activatable Molecular Probes for Optical Imaging Ick Chan Kwon, Ph.D.

tomorrow s innovation changing r amp d model in life
Tomorrow's Innovation: Changing

Tomorrow's Innovation: Changing R&D Model in Life Sciences Jim Sullivan,

comparative effect of various hdac inhibitors in vitro on
Comparative effect of Various

Comparative effect of Various HDAC-inhibitors in-vitro on T- Cell Lymphoma

how we use animal studies to understand
How we use animal studies to understand

How we use animal studies to understand recovery from brain injury Ann M.

dose response approaches for nuclear receptor mediated
Dose-Response Approaches for Nuclear

Dose-Response Approaches for Nuclear Receptor-Mediated Modes of Action

mammary cancer and biomarkers of
Mammary Cancer and Biomarkers of

The Use of Proteomics in Elucidating Mechanisms of Predisposition for Mammary

iomx therapeutics announces discovery of novel druggable
iOmx Therapeutics Announces Discovery

iOmx Therapeutics Announces Discovery of Novel, Druggable Immune-Checkpoint

company presentation october 2019
Company presentation October,2019 1

Oncopeptides Company presentation October,2019 1 Disclaimer IMPORTANT: You